Frontiers in Neurology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 17, 2024
The
innate
immune
response
is
the
body's
first
line
of
defense
against
external
pathogens
and
endogenous
damage
signals.
cGAS-STING
pathway
a
crucial
component
response,
playing
key
role
in
initiating
antiviral
anti-infective
responses
by
recognizing
cytosolic
DNA.
Acute
cerebral
infarction
one
leading
causes
death
disability
worldwide,
with
primary
treatment
approach
being
restoration
blood
flow
to
ischemic
brain
tissue.
However,
reperfusion
injury
remains
significant
challenge
during
treatment.
overactivation
its
association
ischemia-reperfusion
have
been
confirmed
numerous
studies.
This
article
will
systematically
elucidate
mechanisms
pathway,
acute
infarction,
current
research
status
inhibitors,
application
nanomaterials
this
context,
evaluating
therapeutic
potential
pathway.
Journal of Neuroinflammation,
Journal Year:
2025,
Volume and Issue:
22(1)
Published: Feb. 7, 2025
Mitochondrial
dysfunction
is
a
pivotal
instigator
of
neuroinflammation,
with
mitochondrial
DNA
(mtDNA)
leakage
as
critical
intermediary.
This
review
delineates
the
intricate
pathways
leading
to
mtDNA
release,
which
include
membrane
permeabilization,
vesicular
trafficking,
disruption
homeostatic
regulation,
and
abnormalities
in
dynamics.
The
escaped
activates
cytosolic
sensors,
especially
cyclic
gmp-amp
synthase
(cGAS)
signalling
inflammasome,
initiating
neuroinflammatory
cascades
via
pathways,
exacerbating
spectrum
neurological
pathologies.
therapeutic
promise
targeting
discussed
detail,
underscoring
necessity
for
multifaceted
strategy
that
encompasses
preservation
homeostasis,
prevention
leakage,
reestablishment
dynamics,
inhibition
activation
sensors.
Advancing
our
understanding
complex
interplay
between
neuroinflammation
imperative
developing
precision
interventions
disorders.
Molecular Neurodegeneration,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: March 4, 2025
The
relationship
between
Alzheimer's
disease
(AD)
and
neuroimmunity
has
gradually
begun
to
be
unveiled.
Emerging
evidence
indicates
that
cyclic
GMP-AMP
synthase
(cGAS)
acts
as
a
cytosolic
DNA
sensor,
recognizing
damage-associated
molecular
patterns
(DAMPs),
inducing
the
innate
immune
response
by
activating
stimulator
of
interferon
genes
(STING).
Dysregulation
this
pathway
culminates
in
AD-related
neuroinflammation
neurodegeneration.
A
substantial
body
mitochondria
are
involved
critical
pathogenic
mechanisms
AD,
whose
damage
leads
release
mitochondrial
(mtDNA)
into
extramitochondrial
space.
This
leaked
mtDNA
serves
DAMP,
various
pattern
recognition
receptors
defense
networks
brain,
including
cGAS-STING
pathway,
ultimately
leading
an
imbalance
homeostasis.
Therefore,
modulation
mtDNA-cGAS-STING
restore
neuroimmune
homeostasis
may
offer
promising
prospects
for
improving
AD
treatment
outcomes.
In
review,
we
focus
on
during
stress
activation
pathway.
Additionally,
delve
research
progress
further
discuss
primary
directions
potential
hurdles
developing
targeted
therapeutic
drugs,
gain
deeper
understanding
pathogenesis
provide
new
approaches
its
therapy.
Essays in Biochemistry,
Journal Year:
2025,
Volume and Issue:
69(02)
Published: March 7, 2025
The
cyclic
GMP-AMP
synthase-stimulator
of
interferon
genes
(cGAS-STING)
pathway
is
a
crucial
component
the
host's
innate
immunity
and
plays
central
role
in
detecting
cytosolic
double-stranded
DNA
from
endogenous
exogenous
sources.
Upon
activation,
cGAS
synthesizes
cGAMP,
which
binds
to
STING,
triggering
cascade
immune
responses,
including
production
type
I
interferons
pro-inflammatory
cytokines.
In
context
cancers,
cGAS-STING
can
exert
dual
roles:
on
one
hand,
it
promotes
anti-tumor
by
enhancing
antigen
presentation,
stimulating
T-cell
inducing
direct
tumor
cell
apoptosis.
On
other
chronic
particularly
tumors
with
chromosomal
instability,
lead
suppression
progression.
Persistent
signaling
results
up-regulation
checkpoint
molecules
such
as
PD-L1,
contributing
evasion
metastasis.
Consequently,
strategies
targeting
have
consider
balance
activation
tolerance
caused
activation.
This
review
explores
mechanisms
underlying
both
protumor
roles
pathway,
focus
potential
therapeutic
approaches,
challenges
faced
their
clinical
application,
along
corresponding
solutions.
Redox Biology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 103622 - 103622
Published: March 1, 2025
Stroke
is
known
for
its
high
disability
and
mortality
rates.
Ischemic
stroke
(IS),
the
most
prevalent
form,
imposes
a
considerable
burden
on
affected
individuals.
Nevertheless,
existing
treatment
modalities
are
hindered
by
limitations,
including
narrow
therapeutic
windows,
substantial
adverse
effects,
suboptimal
neurological
recovery.
Clarifying
pathological
mechanism
of
IS
prerequisite
developing
new
strategies.
In
this
context,
functional
disruption
mitochondria,
endoplasmic
reticulum
(ER),
crosstalk
mechanisms
between
them
have
garnered
increasing
attention
their
contributory
roles
in
progression
IS.
Therefore,
review
provides
comprehensive
summary
current
pathomechanisms
associated
with
involvement
ER
mitochondria
IS,
emphasising
Ca2+
destabilization
homeostasis,
stress,
oxidative
disordered
mitochondrial
quality
control,
transfer.
Additionally,
article
highlights
interaction
as
well
mitochondrial-ER
contacts
(MERCs)
that
structurally
connect
ER,
aiming
to
provide
ideas
references
research
Cellular and Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
45(1)
Published: April 7, 2025
The
canonical
cyclic
GMP-AMP
(cGAMP)
synthase
(cGAS)-Stimulator
of
Interferon
Genes
(STING)
pathway
has
been
widely
recognized
as
a
crucial
mediator
inflammation
in
many
diseases,
including
tumors,
infections,
and
tissue
damage.
STING
signaling
can
also
be
activated
cGAS-
or
cGAMP-independent
manner,
although
the
specific
mechanisms
remain
unclear.
In-depth
studies
on
structural
molecular
biology
have
led
to
development
therapeutic
strategies
involving
modulators
their
targeted
delivery.
These
may
effectively
penetrate
blood-brain
barrier
(BBB)
target
multiple
central
nervous
system
(CNS)
diseases
humans.
In
this
review,
we
outline
both
non-canonical
pathways
activation
describe
general
associations
between
activity
CNS
diseases.
Finally,
discuss
prospects
for
delivery
clinical
application
agonists
inhibitors,
highlighting
novel
Neurobiology of Disease,
Journal Year:
2024,
Volume and Issue:
202, P. 106710 - 106710
Published: Oct. 28, 2024
Neurodegenerative
diseases
(NDs)
are
a
type
of
common
chronic
progressive
disorders
characterized
by
damage
to
specific
cell
populations
in
the
nervous
system,
ultimately
leading
disability
or
death.
Effective
treatments
for
these
still
lacking,
due
limited
understanding
their
pathogeneses,
which
involve
multiple
cellular
and
molecular
pathways.
The
triggering
an
immune
response
is
feature
neurodegenerative
disorders.
A
critical
challenge
intricate
interplay
between
neuroinflammation,
neurodegeneration,
responses,
not
yet
fully
characterized.
In
recent
years,
cyclic
GMP-AMP
synthase
(cGAS)-stimulator
interferon
gene
(STING)
pathway,
crucial
intracellular
DNA
sensing,
has
gradually
gained
attention.
However,
roles
this
pathway
within
types
such
as
cells,
glial
neuronal
its
contribution
ND
pathogenesis,
remain
elucidated.
review,
we
systematically
explore
how
cGAS-STING
signaling
links
various
with
related
effector
pathways
under
context
NDs
multifaceted
therapeutic
directions.
We
emphasize
discovery
condition-dependent
heterogeneity
integral
diverse
responses
potential
targets.
Additionally,
review
pathogenic
role
activation
Parkinson's
disease,
ataxia-telangiectasia,
amyotrophic
lateral
sclerosis.
focus
on
complex
bidirectional
Alzheimer's
Huntington's
sclerosis,
revealing
double-edged
nature
disease
progression.
objective
elucidate
pivotal
pathogenesis
catalyze
new
insights
facilitating
development
novel
strategies.